milrinone has been researched along with Cardiomyopathy, Dilated in 32 studies
Cardiomyopathy, Dilated: A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the hemodynamic and vasodilating effects of milrinone lactate (ML) in patients with dilated cardiomyopathy (DCM) and New York Heart Association (NYHA) class III and IV heart failure." | 9.09 | Assessment of inotropic and vasodilating effects of milrinone lactate in patients with dilated cardiomyopathy and severe heart failure. ( Bregagnollo, EA; Cicogna, AC; Fortes, AH, 1999) |
| " Metoprolol treatment restores the blunted inotropic response to milrinone in patients with heart failure, indicating that postreceptor events (e." | 9.08 | Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure. ( Böhm, M; Deutsch, HJ; Hartmann, D; Rosée, KL; Stäblein, A, 1997) |
| "Milrinone and dobutamine are positive inotropic agents with beneficial hemodynamic effects in patients with congestive heart failure." | 9.06 | Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy. ( Benotti, JR; Biddle, TL; Creager, MA; Faxon, DP; Firth, BG; Fitzpatrick, PG; Kershner, RP; Konstam, MA; Krebs, C; Walton, L, 1987) |
| "To compare the effects of intravenous dobutamine and milrinone on right ventricular (RV) systolic function, 14 patients with severe congestive heart failure underwent simultaneous radionuclide-hemodynamic study." | 9.06 | Differential effects of milrinone and dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. ( Eichhorn, EJ; Konstam, MA; Martin, TT; Roberts, DJ; Salem, DN; Stransky, NB; Weiland, DS, 1987) |
| " We report a case of severe eosinophil-associated asthma after 6 weeks of therapy with the inotrope dobutamine in a patient awaiting cardiac transplantation." | 7.72 | Dobutamine-related asthma in a patient awaiting cardiac transplantation: the eosinophilic dilemma. ( Aranda, JM; Hill, JA; Pauly, DF; Rodriguez, E; Schofield, RS; Woo, G, 2004) |
| "Hemodynamics during 24-h dobutamine (dob) and subsequent 24-h milrinone (mil) infusion were studied in 20 patients (pts) with severe heart failure (NYHA III: 4 pts, NYHA IV: 16 pts)." | 7.68 | [Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison]. ( Hilger, HH; Höpp, HW; Klocke, RK; Kux, A; Mager, G; Volkmann, A, 1991) |
| "The effects of oral milrinone treatment in cardiomyopathic hamsters with severe congestive heart failure (CHF) were evaluated." | 7.67 | Effects of milrinone treatment in cardiomyopathic hamsters (CHF 147) with severe congestive heart failure. ( Cauchy, MJ; Desjardins, S; Hubert, RS; Mueller, RW, 1989) |
| "To determine whether oral milrinone therapy has an effect on complex ventricular arrhythmias in patients with severe congestive heart failure and, if so, whether a change in the severity of complex ventricular arrhythmias after 1 week of milrinone therapy is associated with a change in the mode or frequency of cardiac mortality, a retrospective analysis was performed to determine the frequency of ventricular tachycardia and the density of ventricular couplets on 24-hour ambulatory electrocardiographic recordings performed before and 1 week after initiation of oral milrinone therapy in 74 consecutive patients with New York Heart Association functional class III or IV congestive heart failure." | 7.67 | Effects of milrinone on complex ventricular arrhythmias in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. ( Antman, EM; Baim, DS; Colucci, WS; Friedman, PL; Gauthier, DF; Ludmer, PL; Rocco, MB, 1987) |
| "End-stage congestive heart failure (CHF) is associated with a high mortality rate and is often refractory to standard medical treatment." | 5.30 | Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study. ( Cesario, D; Clark, J; Maisel, A, 1998) |
| "To assess the hemodynamic and vasodilating effects of milrinone lactate (ML) in patients with dilated cardiomyopathy (DCM) and New York Heart Association (NYHA) class III and IV heart failure." | 5.09 | Assessment of inotropic and vasodilating effects of milrinone lactate in patients with dilated cardiomyopathy and severe heart failure. ( Bregagnollo, EA; Cicogna, AC; Fortes, AH, 1999) |
| " Metoprolol treatment restores the blunted inotropic response to milrinone in patients with heart failure, indicating that postreceptor events (e." | 5.08 | Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure. ( Böhm, M; Deutsch, HJ; Hartmann, D; Rosée, KL; Stäblein, A, 1997) |
| "Milrinone and dobutamine are positive inotropic agents with beneficial hemodynamic effects in patients with congestive heart failure." | 5.06 | Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy. ( Benotti, JR; Biddle, TL; Creager, MA; Faxon, DP; Firth, BG; Fitzpatrick, PG; Kershner, RP; Konstam, MA; Krebs, C; Walton, L, 1987) |
| "To compare the effects of intravenous dobutamine and milrinone on right ventricular (RV) systolic function, 14 patients with severe congestive heart failure underwent simultaneous radionuclide-hemodynamic study." | 5.06 | Differential effects of milrinone and dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. ( Eichhorn, EJ; Konstam, MA; Martin, TT; Roberts, DJ; Salem, DN; Stransky, NB; Weiland, DS, 1987) |
| "The aim of this study was to assess the safety and efficacy of long-term milrinone therapy in children with acute decompensated heart failure due to dilated cardiomyopathy (DCM)." | 4.31 | Long-term milrinone therapy in children with dilated cardiomyopathy. ( Botha, P; Brown, S; Cassidy, J; Chaudhari, M; Kidd, J; Nolan, O; Poole, E, 2023) |
| "A four- and a half-month-old girl with severe dilated cardiomyopathy due to neonatal enterovirus myocarditis, treated with diuretics and milrinone for the past 4 months, was infected with SARS-CoV-2." | 4.02 | SARS-CoV-2 infection in an infant with severe dilated cardiomyopathy. ( Knudsen, PK; Kristoffersen, AW; Møller, T, 2021) |
| " We report a case of severe eosinophil-associated asthma after 6 weeks of therapy with the inotrope dobutamine in a patient awaiting cardiac transplantation." | 3.72 | Dobutamine-related asthma in a patient awaiting cardiac transplantation: the eosinophilic dilemma. ( Aranda, JM; Hill, JA; Pauly, DF; Rodriguez, E; Schofield, RS; Woo, G, 2004) |
| "Hemodynamics during 24-h dobutamine (dob) and subsequent 24-h milrinone (mil) infusion were studied in 20 patients (pts) with severe heart failure (NYHA III: 4 pts, NYHA IV: 16 pts)." | 3.68 | [Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison]. ( Hilger, HH; Höpp, HW; Klocke, RK; Kux, A; Mager, G; Volkmann, A, 1991) |
| "The effects of oral milrinone treatment in cardiomyopathic hamsters with severe congestive heart failure (CHF) were evaluated." | 3.67 | Effects of milrinone treatment in cardiomyopathic hamsters (CHF 147) with severe congestive heart failure. ( Cauchy, MJ; Desjardins, S; Hubert, RS; Mueller, RW, 1989) |
| "To determine whether oral milrinone therapy has an effect on complex ventricular arrhythmias in patients with severe congestive heart failure and, if so, whether a change in the severity of complex ventricular arrhythmias after 1 week of milrinone therapy is associated with a change in the mode or frequency of cardiac mortality, a retrospective analysis was performed to determine the frequency of ventricular tachycardia and the density of ventricular couplets on 24-hour ambulatory electrocardiographic recordings performed before and 1 week after initiation of oral milrinone therapy in 74 consecutive patients with New York Heart Association functional class III or IV congestive heart failure." | 3.67 | Effects of milrinone on complex ventricular arrhythmias in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. ( Antman, EM; Baim, DS; Colucci, WS; Friedman, PL; Gauthier, DF; Ludmer, PL; Rocco, MB, 1987) |
| "Milrinone was administered intravenously in successive doses of 25, 50, and 75 micrograms/kg." | 2.66 | Milrinone in the treatment of chronic cardiac failure: a controlled trial. ( Andrews, V; Janicki, JS; Likoff, MJ; Rocci, ML; Weber, KT; Wilson, H, 1985) |
| "Their mitral regurgitation (MR) is a result of left ventricular (LV) geometrical distortion." | 1.33 | Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair. ( Bolling, SF; Geltz, A; Spoor, MT, 2006) |
| "Milrinone was effective as a pharmacological bridge to heart transplantation in this patient with terminal and critical heart failure after removal of a left ventricular assist device." | 1.31 | Clinical experience of milrinone as a pharmacological bridge to heart transplantation. ( Asano, H; Koyanagi, T; Kyo, S; Omoto, R; Ouchi, H; Yokote, Y, 2000) |
| "End-stage congestive heart failure (CHF) is associated with a high mortality rate and is often refractory to standard medical treatment." | 1.30 | Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study. ( Cesario, D; Clark, J; Maisel, A, 1998) |
| "A 42-year-old man with dilated cardiomyopathy and rheumatic mitral stenosis underwent mitral valve replacement." | 1.30 | [Anesthetic management for mitral valve replacement in a patient with mitral stenosis and dilated cardiomyopathy]. ( Fujihara, H; Fukuda, S; Kurokawa, S; Shimoji, K; Tobita, T, 1999) |
| "Twelve adult patients with dilated cardiomyopathy were studied (6 ischemic in origin and 6 idiopathic), 7 of whom were being considered for cardiac transplantation." | 1.29 | Effects of intravenous milrinone on left ventricular function in ischemic and idiopathic dilated cardiomyopathy. ( Brecker, SJ; Gibson, DG; Mbaissouroum, M; Xiao, HB, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (15.63) | 18.7374 |
| 1990's | 11 (34.38) | 18.2507 |
| 2000's | 7 (21.88) | 29.6817 |
| 2010's | 7 (21.88) | 24.3611 |
| 2020's | 2 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, S | 1 |
| Nolan, O | 1 |
| Poole, E | 1 |
| Kidd, J | 1 |
| Cassidy, J | 1 |
| Botha, P | 1 |
| Chaudhari, M | 1 |
| Kristoffersen, AW | 1 |
| Knudsen, PK | 1 |
| Møller, T | 1 |
| Soucy-Giguere, MC | 1 |
| Charbonneau, É | 1 |
| Cinq Mars, A | 1 |
| Dubois, M | 1 |
| Sénéchal, M | 1 |
| Donnell, SA | 1 |
| Young, TW | 1 |
| Steele, RW | 1 |
| Goldberg, JF | 1 |
| Adachi, I | 1 |
| Kirk, R | 1 |
| Peng, E | 1 |
| Woods, A | 1 |
| Flett, J | 1 |
| Hewitt, T | 1 |
| Griselli, M | 1 |
| Schueler, S | 1 |
| Wrightson, N | 1 |
| Hasan, A | 1 |
| Nakano, SJ | 1 |
| Nelson, P | 1 |
| Sucharov, CC | 1 |
| Miyamoto, SD | 1 |
| Sasaki, N | 1 |
| Joashi, UC | 1 |
| Vergara, M | 1 |
| Saland, JM | 1 |
| Love, BA | 1 |
| Nakamura, T | 1 |
| Ikeshita, K | 1 |
| Shimizu, M | 1 |
| Miyake, W | 1 |
| Ikeda, Y | 1 |
| Asada, A | 1 |
| Kato, M | 1 |
| Hirayama, A | 1 |
| Hill, JA | 2 |
| Hsu, K | 1 |
| Pauly, DF | 2 |
| Schofield, R | 1 |
| Aranda, JM | 2 |
| Woo, G | 1 |
| Rodriguez, E | 1 |
| Schofield, RS | 1 |
| Chi, NH | 1 |
| Huang, SC | 1 |
| Yu, HY | 1 |
| Chen, YS | 1 |
| Wang, SS | 1 |
| Sablotzki, A | 1 |
| Starzmann, W | 1 |
| Scheubel, R | 1 |
| Grond, S | 1 |
| Czeslick, EG | 1 |
| Spoor, MT | 1 |
| Geltz, A | 1 |
| Bolling, SF | 1 |
| Zimmermann, W | 1 |
| Scholz, H | 1 |
| Schumacher, C | 1 |
| Wenzlaff, H | 1 |
| Haverich, A | 1 |
| Brecker, SJ | 1 |
| Xiao, HB | 1 |
| Mbaissouroum, M | 1 |
| Gibson, DG | 1 |
| Böhm, M | 3 |
| Deutsch, HJ | 1 |
| Hartmann, D | 1 |
| Rosée, KL | 1 |
| Stäblein, A | 1 |
| Smith, CJ | 1 |
| Huang, R | 1 |
| Sun, D | 1 |
| Ricketts, S | 1 |
| Hoegler, C | 1 |
| Ding, JZ | 1 |
| Moggio, RA | 1 |
| Hintze, TH | 1 |
| Cesario, D | 1 |
| Clark, J | 1 |
| Maisel, A | 1 |
| Kurokawa, S | 1 |
| Fujihara, H | 1 |
| Tobita, T | 1 |
| Fukuda, S | 1 |
| Shimoji, K | 1 |
| Bregagnollo, EA | 1 |
| Fortes, AH | 1 |
| Cicogna, AC | 1 |
| Koyanagi, T | 1 |
| Kyo, S | 1 |
| Ouchi, H | 1 |
| Asano, H | 1 |
| Yokote, Y | 1 |
| Omoto, R | 1 |
| Gierschik, P | 2 |
| Erdmann, E | 2 |
| Mager, G | 2 |
| Steffen, HM | 1 |
| Klocke, RK | 2 |
| Wambach, G | 1 |
| Kux, A | 2 |
| Degenhardt, S | 1 |
| Höpp, HW | 2 |
| Hilger, HH | 2 |
| Volkmann, A | 1 |
| Jakobs, KH | 1 |
| Pieske, B | 1 |
| Schnabel, P | 1 |
| Ungerer, M | 1 |
| Desjardins, S | 1 |
| Mueller, RW | 1 |
| Hubert, RS | 1 |
| Cauchy, MJ | 1 |
| Biddle, TL | 1 |
| Benotti, JR | 1 |
| Creager, MA | 1 |
| Faxon, DP | 1 |
| Firth, BG | 1 |
| Fitzpatrick, PG | 1 |
| Konstam, MA | 2 |
| Krebs, C | 1 |
| Walton, L | 1 |
| Kershner, RP | 1 |
| Ludmer, PL | 1 |
| Baim, DS | 1 |
| Antman, EM | 1 |
| Gauthier, DF | 1 |
| Rocco, MB | 1 |
| Friedman, PL | 1 |
| Colucci, WS | 1 |
| Eichhorn, EJ | 1 |
| Weiland, DS | 1 |
| Roberts, DJ | 1 |
| Martin, TT | 1 |
| Stransky, NB | 1 |
| Salem, DN | 1 |
| Likoff, MJ | 1 |
| Weber, KT | 1 |
| Andrews, V | 1 |
| Janicki, JS | 1 |
| Wilson, H | 1 |
| Rocci, ML | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| 2- Inhaled Milrinone Prevents the Increase in Pulmonary Artery Pressure After CPB[NCT00819377] | Phase 2 | 124 participants (Anticipated) | Interventional | 2009-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for milrinone and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
[Combination therapy; dobutamine and milrinone].
Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; H | 2011 |
7 trials available for milrinone and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Selective pulmonary vasodilation with inhaled aerosolized milrinone in heart transplant candidates.
Topics: Adult; Aerosols; Blood Volume; Cardiomyopathy, Dilated; Extravascular Lung Water; Heart Transplantat | 2005 |
Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Drug Synergis | 1997 |
Assessment of inotropic and vasodilating effects of milrinone lactate in patients with dilated cardiomyopathy and severe heart failure.
Topics: Adult; Cardiomyopathy, Dilated; Cardiotonic Agents; Female; Heart Failure; Hemodynamics; Humans; Mal | 1999 |
[The effect of hemodynamic changes in 24-hour milrinone infusion on sympathetic activity and the renin-angiotensin-aldosterone system in patients with severe heart failure].
Topics: Adult; Cardiomyopathy, Dilated; Cardiotonic Agents; Catecholamines; Coronary Disease; Drug Administr | 1991 |
Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy.
Topics: Cardiomyopathy, Dilated; Coronary Disease; Dobutamine; Heart Failure; Hemodynamics; Humans; Infusion | 1987 |
Differential effects of milrinone and dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; Humans | 1987 |
Milrinone in the treatment of chronic cardiac failure: a controlled trial.
Topics: Administration, Oral; Aged; Atrial Fibrillation; Cardiomyopathy, Dilated; Chronic Disease; Clinical | 1985 |
24 other studies available for milrinone and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Long-term milrinone therapy in children with dilated cardiomyopathy.
Topics: Cardiomyopathy, Dilated; Child; Heart Failure; Heart Transplantation; Humans; Infant; Milrinone; Ret | 2023 |
SARS-CoV-2 infection in an infant with severe dilated cardiomyopathy.
Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; COVID-19; Diarrhea; Diuretics; Echocardiography; Entero | 2021 |
Temporary left ventricular assist device for complete recovery from reversible acute heart failure due to tumor necrosis factor-α inhibitor.
Topics: Adult; Arthritis; Cardiomyopathy, Dilated; Cardiotonic Agents; Crohn Disease; Etanercept; Female; Fu | 2019 |
A toddler in distress.
Topics: Abdominal Pain; Cardiomyopathy, Dilated; Cardiotonic Agents; Child, Preschool; Diagnosis, Differenti | 2015 |
Pulmonary Artery Band as Bridge to Ventricular Assist Device by Preconditioning of the Right Ventricle.
Topics: Cardiac Catheterization; Cardiomyopathy, Dilated; Female; Follow-Up Studies; Heart Transplantation; | 2016 |
Successful HeartWare Bridge to Recovery in a 3-Year Old: A Game Changer?
Topics: Anticoagulants; Biopsy; Cardiomyopathy, Dilated; Child, Preschool; Combined Modality Therapy; Heart | 2016 |
Myocardial Response to Milrinone in Single Right Ventricle Heart Disease.
Topics: Adenosine Monophosphate; Calcium-Binding Proteins; Cardiomyopathy, Dilated; Child; Child, Preschool; | 2016 |
Postrenal biopsy AVM leading to severe hypertension and dilated cardiomyopathy.
Topics: Arteriovenous Fistula; Arteriovenous Malformations; Biopsy; Cardiomyopathy, Dilated; Cardiotonic Age | 2009 |
[Anesthetic management for mitral valve replacement in a patient with mitral stenosis and dilated cardiomyopathy].
Topics: Aged; Anesthesia, General; Cardiomyopathy, Dilated; Cardiopulmonary Bypass; Heart Valve Prosthesis I | 2011 |
Sustained use of nesiritide to aid in bridging to heart transplant.
Topics: Adult; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Diuretics; Dobutamine; Dopamin | 2003 |
Dobutamine-related asthma in a patient awaiting cardiac transplantation: the eosinophilic dilemma.
Topics: Asthma; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Eosinophilia; Heart Transplantation | 2004 |
Application of papillary muscle sling concept in an infant as a biological bridge to transplantation.
Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; Combined Modality Therapy; Disease Progression; Heart F | 2005 |
Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiomyopathy, Dilated; Combined Modality | 2006 |
Effects of saterinone and its enantiomers R(+)-saterinone and S(-)-saterinone on the phosphodiesterase isoenzymes from ventricular tissue of failing human hearts and porcine hearts.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Animals; Cardiac Output, Low; Cardiomyopathy, Dilated; Cardioton | 1994 |
Effects of intravenous milrinone on left ventricular function in ischemic and idiopathic dilated cardiomyopathy.
Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; Echocardiography; Echocardiography, Doppler; Hemodynami | 1993 |
Development of decompensated dilated cardiomyopathy is associated with decreased gene expression and activity of the milrinone-sensitive cAMP phosphodiesterase PDE3A.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Blotting, Northern; Cardiac Pacing, Artificial; Cardio | 1997 |
Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study.
Topics: Adult; Aged; Aged, 80 and over; Cardiomyopathy, Dilated; Cardiotonic Agents; Drug Administration Sch | 1998 |
[Anesthetic management for mitral valve replacement in a patient with mitral stenosis and dilated cardiomyopathy].
Topics: Adult; Anesthesia, Intravenous; Anesthetics, Intravenous; Cardiomyopathy, Dilated; Dobutamine; Dopam | 1999 |
Clinical experience of milrinone as a pharmacological bridge to heart transplantation.
Topics: Adult; Cardiomyopathy, Dilated; Heart Transplantation; Humans; Male; Milrinone; Phosphodiesterase In | 2000 |
Quantification of Gi alpha-proteins in the failing and nonfailing human myocardium.
Topics: Amino Acid Sequence; Antibodies; Cardiomyopathy, Dilated; Coronary Disease; GTP-Binding Proteins; He | 1992 |
[Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison].
Topics: Adult; Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Dobutamine; Dose-Respons | 1991 |
Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy.
Topics: Adenosine Diphosphate Ribose; Adenylate Cyclase Toxin; Adenylyl Cyclases; Adult; Carbachol; Cardiomy | 1990 |
Effects of milrinone treatment in cardiomyopathic hamsters (CHF 147) with severe congestive heart failure.
Topics: Animals; Body Weight; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Cricetinae; Disease Mode | 1989 |
Effects of milrinone on complex ventricular arrhythmias in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Ambulatory Care; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Coronary Disease; Elect | 1987 |